ESHG 2023

SOPHiA GENETICS™ is excited to be a part of the European Society of Human Genetics annual meeting, held in person in Glasgow, Scotland, UK from June 10th-13th.

You will have the chance to chat with our experts at booth #606 and demo the universal SOPHiA DDM™ Platform. 

We are also happy to invite you to our symposium taking place on Sunday, June 11, from 08.30am to 10.00am BST at level 0 in room Alsh 2. See here below for the details:

Progress in the Adoption of Exome and Pharmacogenetics Analysis

At SOPHiA GENETICS, we collaborate with genetic experts to develop specialized next-generation sequencing (NGS) applications that seamlessly integrate into any laboratory workflow. Today, our partners share how the analytical technology and dedicated features in the SOPHiA DDM™️ Platform have enabled the accurate detection and streamlined assessment of variants associated with Rare Diseases and Pharmacogenomics.

Join us to discover how the SOPHiA DDM™️ Platform:

  • Successfully enabled the discovery of complex variants associated with genetic diseases using exome sequencing.
  • Was seamlessly integrated into routine NGS workflows for pharmacogenetic analysis.

You cannot join us onsite in Glasgow? Not a problem, ESHG is a hybrid event. Register to the event for online participation and watch our talk live: https://ter.li/yqsjfh

Event Date
June 10, 2023 – June 13, 2023

Event Type

In-person

Event Location

Europe

Areas of Interest

Hereditary Disorders, Hereditary Cancer, Alamut

Disclaimer notice:

The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.

The opinions expresseda during this presentation are these of the speaker and may not represent the opinions of SOPHiA GENETICS.

SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';